William M. Scalzulli
Direktor/Vorstandsmitglied bei Dune Medical Devices Ltd.
Profil
William M.
Scalzulli is currently a Director at Dune Medical Devices Ltd.
and Dune Medical Devices, Inc. He previously served as a Director at Acetylon Pharmaceuticals, Inc., Spero Therapeutics, Inc., and C4 Therapeutics, Inc. He holds a graduate degree from Boston University and an undergraduate degree from Northeastern University.
Aktive Positionen von William M. Scalzulli
| Unternehmen | Position | Beginn |
|---|---|---|
Dune Medical Devices Ltd.
 Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel. | Direktor/Vorstandsmitglied | - |
Dune Medical Devices, Inc.
 Dune Medical Devices, Inc. Medical SpecialtiesHealth Technology Dune Medical Devices, Inc. engages in the development, manufacture, and commercialization of medical devices for cancer surgery providing real-time tissue characterization systems. It focuses guiding on surgical and diagnostic decisions. The company was founded by Dan Hashimshony in 2002 and is headquartered in Alpharetta, GA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von William M. Scalzulli
| Unternehmen | Position | Ende |
|---|---|---|
| C4 THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.06.2020 |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
| SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von William M. Scalzulli
| Boston University | Graduate Degree |
| Northeastern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Dune Medical Devices Ltd.
Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel. | Health Technology |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Dune Medical Devices, Inc.
Dune Medical Devices, Inc. Medical SpecialtiesHealth Technology Dune Medical Devices, Inc. engages in the development, manufacture, and commercialization of medical devices for cancer surgery providing real-time tissue characterization systems. It focuses guiding on surgical and diagnostic decisions. The company was founded by Dan Hashimshony in 2002 and is headquartered in Alpharetta, GA. | Health Technology |
